Nitinol forms Dutch subsidiary:
This article was originally published in Clinica
Nitinol Medical Technologies has formed a subsidiary in the Netherlands in preparation for the European launch of CardioSeal, expected later this year. The product is for the minimally invasive repair of defects in the septal wall of the heart, which mainly occur in children. Gert Jansen becomes European director of sales and marketing in the new company, which is based in Rotterdam.